Impact of anemia on the clinical outcomes in elderly patients with atrial fibrillation receiving apixaban: J-ELD AF registry subanalysis

Furberg, 1994, Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study), Am. J. Cardiol., 74, 236, 10.1016/0002-9149(94)90363-8 Inoue, 2009, Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination, Int. J. Cardiol., 137, 102, 10.1016/j.ijcard.2008.06.029 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Abdel-Qadir, 2018, Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation, Circ. Cardiovasc. Qual. Outcomes., 11, 10.1161/CIRCOUTCOMES.118.004580 Malik, 2019, Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age, Am. J. Cardiol., 123, 2051, 10.1016/j.amjcard.2019.02.060 Lim, 2020, Impact of Hemoglobin Levels and Their Dynamic Changes on the Risk of Atrial Fibrillation: A Nationwide Population-Based Study, Sci. Rep., 10, 6762, 10.1038/s41598-020-63878-9 Kodani, 2020, Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry, Int. J. Cardiol., 302, 81, 10.1016/j.ijcard.2019.11.127 An, 2020, Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry), Am. J. Cardiol., 134, 74, 10.1016/j.amjcard.2020.08.009 D. Steensma, A. Tefferi, Anemia in the Elderly: how should we define it, when does it matter, and what can be done? Mayo Clin. Proc. 82 (2007) 958–966. Stauder, 2018, Anemia at older age: etiologies, clinical implications, and management, Blood, 131, 505, 10.1182/blood-2017-07-746446 Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17;361(12):1139-51. 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877. PMID: 19717844. Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl. J. Med., 365, 883, 10.1056/NEJMoa1009638 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N. Engl. J. Med., 365, 981, 10.1056/NEJMoa1107039 Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl. J. Med., 369, 2093, 10.1056/NEJMoa1310907 Okumura, 2020, A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J‐ELD AF Registry), Clin. Cardiol., 43, 251, 10.1002/clc.23294 Akao M, Yamashita T, Suzuki S, Okumura K; J-ELD AF investigators. Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis. Am Heart J. 2020 May;223:23-33. 10.1016/j.ahj.2020.02.007. Epub 2020 Feb 8. Erratum in: Am Heart J. 2020 Apr 13;: Erratum in: Am Heart J. 2021 Mar;233:153. PMID: 32135338. Suzuki S, Yamashita T, Akao M, Okumura K; J-ELD AF investigators. Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis. Eur J Clin Pharmacol. 2020 Aug;76(8):1111-1124. 10.1007/s00228-020-02896-y. Epub 2020 May 25. PMID: 32451850. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37. Westenbrink, 2017, Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, Am. Heart J., 185, 140, 10.1016/j.ahj.2016.12.008 Westenbrink, 2015, Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial, J. Thromb. Haemost., 13, 699, 10.1111/jth.12874 Tu SJ, Hanna-Rivero N, Elliott AD, Clarke N, Huang S, Pitman BM, et al. Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021 Jan 10.1111/jce.14898. Epub ahead of print. PMID: 33476452. Suzuki, 2021, Identifying risk patterns in older adults with atrial fibrillation by hierarchical cluster analysis: A retrospective approach based on the risk probability for clinical events, Int. J. Cardiol. Heart Vasc., 37, 100883 Sharma S, Gage BF, Deych E, Rich MW. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J. 2009 Jun;157(6):1057-63. 10.1016/j.ahj.2009.03.009. Epub 2009 Apr 25. PMID: 19464417. Sharma, 2015, Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis, Circulation, 132, 194, 10.1161/CIRCULATIONAHA.114.013267